Discussion of Histopathological Findings of 954 Breast Reduction Specimens.
Breast reduction
histopathologic result
nonproliferative breast lesion
proliferative breast lesion
Journal
Sisli Etfal Hastanesi tip bulteni
ISSN: 1302-7123
Titre abrégé: Sisli Etfal Hastan Tip Bul
Pays: Turkey
ID NLM: 9424130
Informations de publication
Date de publication:
2021
2021
Historique:
received:
14
04
2020
accepted:
07
06
2020
entrez:
3
5
2021
pubmed:
4
5
2021
medline:
4
5
2021
Statut:
epublish
Résumé
Breast reduction is a frequently sought procedure by patients and one of the most commonly performed operations by plastic surgeons. Follow-up of histopathological results after reduction mammoplasty is very important. This study aimed to evaluate the histopathological results of patients undergoing bilateral reduction mammoplasty to determine the incidence of breast lesions and risk factors of high-risk breast lesions. 477 patients who underwent reduction mammoplasty in the plastic surgery department between October 2013 and January 2020 were included in this study. Patients were evaluated according to age, body mass index (BMI), comorbidity factors, tobacco use, family history and histopathological findings. The mean age of patients was 42.43±12.05 years. Body mass index ranged from 23 to 34.6. As for comorbidity factors, 12 patients had hypertension, five patients had asthma and six patients had diabetes mellitus. Seventeen patients (3.6%) were smokers, and 25 (5.2%) patients had a family history of breast cancer. Among the patients, 2.3% were 20 years and under, 17.1% were between 21 and 30 years old, 21.5% were between 31 and 40 years old, 33.1% were between 41 and 50 years old, 18.2% were between 51 and 60 years old, and 7.5% were 60 years and above. 85.4% of histopathological findings consisted of normal breast tissue and nonproliferative breast lesion breast lesions. The incidences of proliferative breast lesions, atypical hyperplasia and in situ lesions were calculated as 5.7%, 2% and 0.4%, respectively. The mean follow-up period was 3.8±1.6 years. Although preoperative breast cancer screening methods are used before the reduction mammoplasty, high-risk lesions may be encountered afterwards. One of the biggest advantages of reduction mammoplasty in addition to psychophysiological recovery is breast cancer risk reduction.
Identifiants
pubmed: 33935534
doi: 10.14744/SEMB.2020.33349
pii: MBSEH-55-42
pmc: PMC8085449
doi:
Types de publication
Journal Article
Langues
eng
Pagination
42-48Informations de copyright
Copyright: © 2021 by The Medical Bulletin of Sisli Etfal Hospital.
Déclaration de conflit d'intérêts
Conflict of Interest: No conflict of interest is declared by the authors.
Références
Breast Cancer Res Treat. 2019 Oct;177(3):741-748
pubmed: 31317348
Plast Reconstr Surg. 2009 Nov;124(5):1386-1392
pubmed: 20009822
Plast Reconstr Surg. 2003 Feb;111(2):688-94
pubmed: 12560689
Plast Reconstr Surg. 1999 May;103(6):1674-81
pubmed: 10323701
Ann Plast Surg. 2018 Jul;81(1):36-38
pubmed: 29762441
Ann Plast Surg. 2016 Jun;76(6):700-4
pubmed: 25003417
Histopathology. 2020 Jun;76(7):988-996
pubmed: 32043273
Hum Pathol. 2013 Sep;44(9):1877-81
pubmed: 23656973
Breast Cancer Res Treat. 2019 Jan;173(1):201-207
pubmed: 30238276
Breast. 2005 Jun;14(3):242-8
pubmed: 15927834
Eur J Surg Oncol. 2005 Feb;31(1):19-21
pubmed: 15642421
Arch Pathol Lab Med. 1998 Dec;122(12):1053-5
pubmed: 9870852
BMC Cancer. 2017 Dec 02;17(1):808
pubmed: 29197354
J Plast Surg Hand Surg. 2014 Apr;48(2):122-5
pubmed: 23879776
Scand J Plast Reconstr Surg Hand Surg. 2009;43(4):201-6
pubmed: 19688643
Aesthetic Plast Surg. 2002 May-Jun;26(3):203-5
pubmed: 12140700
Plast Reconstr Surg. 2011 Feb;127(2):525-530
pubmed: 21285757
Ann Plast Surg. 2004 Feb;52(2):126-30
pubmed: 14745259
Arch Pathol Lab Med. 2017 Nov;141(11):1523-1528
pubmed: 28795842
J Surg Oncol. 1998 Mar;67(3):168-73
pubmed: 9530887
Plast Reconstr Surg. 2004 Jun;113(7):1984-8
pubmed: 15253187
Am J Clin Pathol. 2003 Sep;120(3):377-80
pubmed: 14502800
Ann Plast Surg. 2013 Jun;70(6):639-42
pubmed: 23123605
Int J Endocrinol. 2015;2015:719824
pubmed: 26550014
Clin Obstet Gynecol. 2016 Dec;59(4):710-726
pubmed: 27660928
Cancer. 1989 Nov 15;64(10):1977-83
pubmed: 2804888
Plast Reconstr Surg. 2009 Oct;124(4):1033-1039
pubmed: 19935286
Int J Cancer. 2003 Aug 10;106(1):96-102
pubmed: 12794763
J Plast Reconstr Aesthet Surg. 2017 Feb;70(2):196-202
pubmed: 27908767
Nutr Cancer. 2003;45(1):1-16
pubmed: 12791499
Ginekol Pol. 1999 Jan;70(1):1-7
pubmed: 10349800
Turk J Med Sci. 2015;45(6):1374-9
pubmed: 26775397
Breast J. 2019 May;25(3):439-443
pubmed: 30924231
Histopathology. 1985 Mar;9(3):281-5
pubmed: 3997085
N Engl J Med. 1985 Jan 17;312(3):146-51
pubmed: 3965932
Br J Cancer. 1996 Apr;73(7):961-3
pubmed: 8611415
Plast Reconstr Surg. 2005 Mar;115(3):729-34; discussion 735
pubmed: 15731670